Disrupting Pharmaceuticals
Alex shares his journey of co-founding Cost Plus Drugs with Mark, emphasizing the challenges of disrupting the pharmaceutical industry. He highlights the anti-competitive tactics faced and how a bold cold email led to a partnership with Mark, who is now deeply involved in the mission to lower drug prices. The conversation reveals the innovative strategies being employed to tackle an issue that has eluded public policy for decades.In this clip
From this podcast
Masters of Scale
Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky
Related Questions